knowledge -WSS

knowledge

author：fashion 2025-09-07 17:26:18 - browse：9438

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Eliminate the waiting period for sterilization covered by Medicaid

hotspot

WSS

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

California’s proposed $25 per hour health care minimum wage

New research casts further doubt on a common procedure used with IVF

Primary care physicians play key roles in Alzheimer's management

Vertex Pharmaceuticals may move headquarters in Boston

Decaf coffee targeted by food safety group under obscure FDA rule

leisure time

knowledge

focus

Medicare proposal to cover medical devices draws a mixed reaction

Primary care physicians play key roles in Alzheimer's management

Tori Bowie and the unacceptable rates of Black maternal death

Beach reads and more: STAT's 2023 summer book list

BioMarin wins approval for gene therapy to treat hemophilia A

Steward Health Care has deal to sell doctor network to UnitedHealth

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Bright Health sells Medicare Advantage business to Molina

Why 40% Americans with Parkinson’s don’t see a neurologist

hotspot

Steward Health Care has deal to sell doctor network to UnitedHealth

FDA's naming rule on biosimilars has undermined competition

Iowa House, Senate pass 6

FDA's naming rule on biosimilars has undermined competition

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

hotspot

focus

entertainment

Wikipedia